Renalytix Plc. has returned -99.8% from $13.00 since 2021, trailing SPY's +70.2% over the same period. The stock hit an all-time high of $17.15 in May 2021 and is currently 99.9% below that level. 4 news events tracked with market reaction data.
Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.
Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.
Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.
Want the full written briefing?
The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.
| Date | Return | Category | Source | Headline |
|---|---|---|---|---|
| 2025-09-15 | +172.9% | news | Yahoo Finance | Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease - Yahoo Finance |
| 2021-10-20 | -0.7% | earnings | Seeking Alpha | Renalytix: Building Out A Capability To Ramp Revenue |
| 2026-02-23 | +0.3% | news | Stock Titan | RENXF SEC Filings - Renalytix Plc 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2025-03-18 | +0.0% | earnings | Seeking Alpha | Renalytix AI GAAP EPS of -$0.05, revenue of $1.25M; reaffirms outlook |